Loading...
Keywords
Last Name
Institution

Connection

Search Results to Matthew J. McLaughlin

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of McLaughlin, Matthew

PropertyValue
keywords Clinical Pharmacology
keywords Pediatric Physical Medicine/Rehabilitation
research overview Matt McLaughlin is a Pediatric Rehabilitation Medicine physician and Clinical Pharmacologist. His primary research centers on optimizing “the right medication for the right patient at the right time to improve outcomes.” He completed the MD/BA 6-year program at the University of Missouri-Kansas City prior to starting his fellowship at the University of Missouri-Columbia. After graduation from residency, he pursued a clinical Pediatric Rehabilitation Medicine fellowship at Children’s Mercy Hospital in Kansas City. During this time, he obtained his Masters in Medical Bioinformatics to help with clinical research design and database management. Upon graduation, he was named a Vice Chancellors Honors Recipient for obtaining a 4.0 GPA while also positively contributing to the Kansas City community. He received advance training in Clinical Pharmacology by participating in an NICHD T32 Fellowship in Pediatric Clinical and Developmental Pharmacology prior to starting his K12 funding. He has been funded since that time by an NIH/NICHD R03 Award. Dr. McLaughlin’s primary research work has centered around precision medicine in pediatric patients with cerebral palsy (CP). Clinically, he remains passionate about how to employ the pharmacogenetics associated with alterations in medication absorption, distribution, elimination and metabolism with improving clinical outcomes. He employs aspects of pharmacokinetic modeling, pharmacogenomics and clinical trial design in his studies. His work has already earned him several notable awards during his career. He is currently a Professor in the Department of Pediatrics at Children’s Mercy – Kansas City where he serves as the Division Director of Rehabilitation Medicine. Recognizing the need for leadership and fiscal responsibility in research, he completed a dual degree program from University of Texas at Dallas in 2024 (Master of Business Administration/Master in Healthcare Leadership and Management).

One or more keywords matched the following items that are connected to McLaughlin, Matthew

Item TypeName
Concept Pediatrics
Academic Article The Interplay between Pharmacokinetics and Pharmacodynamics.
Grant Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology
Grant Genomic- and Ontogeny-Linked Dose Individualization and cLinical Optimization for Kids
Academic Article Examining the role of precision medicine with oral baclofen in pediatric patients with cerebral palsy.
Academic Article Variability of Steady State Oral Baclofen Prescribing Practices in Pediatric Patients With Cerebral Palsy.
Award or Honor Receipt Presidential Trainee Award
Award or Honor Receipt Blue Ribbon for Top Poster
Academic Article Safe and effective medication utilization in pediatric patients requiring rehabilitation services during the Coronavirus pandemic of 2019.
Academic Article A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19).
Academic Article Acute Imaging Findings Predict Recovery of Cognitive and Motor Function after Inpatient Rehabilitation for Pediatric Traumatic Brain Injury: A Pediatric Brain Injury Consortium Study.
Academic Article Cognitive Recovery During Inpatient Rehabilitation Following Pediatric Traumatic Brain Injury: A Pediatric Brain Injury Consortium Study.
Academic Article Decreased clinical response to therapy in pediatric patients with cerebral palsy: Current trends and challenges.
Academic Article Prescribing Patterns of Amantadine During Pediatric Inpatient Rehabilitation After Traumatic Brain Injury: A Multicentered Retrospective Review From the Pediatric Brain Injury Consortium.
Academic Article A Consensus Statement on the use of Botulinum Toxin in Pediatric Patients.
Grant Variability in Gabapentin Exposure in Children with Cerebral Palsy
Academic Article Determining the impact of a clinic coordinator on patient access and clinic efficiency in a pediatric multidisciplinary spina bifida clinic using medical informatics.
Academic Article Dosing Variability and Clinical Outcomes of Oxybutynin: A Pediatric Cohort of Patients With Neurogenic Bladder.
Academic Article A critical evaluation of oral baclofen in pediatric patients with cerebral palsy.
Award or Honor Receipt Darrell Abernethy Early Stage Investigator Award
Grant Precision Medicine in Pediatric Rehabilitation - Variability in Gabapentin Exposure
Academic Article The Use of Methylphenidate During Inpatient Rehabilitation After Pediatric Traumatic Brain Injury: Population Characteristics and Prescribing Patterns.

Search Criteria
  • Pediatric
  • Clinical Pharmacology